Fluctuations of Plasma β2-Microglobulin, Soluble Interleukin 2 Receptor and Interferon-Gamma Concentrations after Adoptive Immunotherapy with High-Dose Interleukin 2 and Lymphokine-Activated Killer Cells
- 1 February 1989
- journal article
- research article
- Published by Elsevier in Immunobiology
- Vol. 178 (4-5), 305-315
- https://doi.org/10.1016/s0171-2985(89)80054-3
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- THE SOLUBLE INTERLEUKIN‐2 RECEPTOR IN HAEMATOLOGICAL DISORDERSBritish Journal of Haematology, 1987
- Cell surface expression of beta 2-microglobulin (beta 2m) correlates with stages of differentiation in B cell tumours.Journal of Clinical Pathology, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.The Journal of Experimental Medicine, 1984
- Serum beta 2-microglobulin and C reactive protein concentrations in viral infections.Journal of Clinical Pathology, 1984
- Serum Beta-2-Microglobulin in Disorders of Myeloid ProliferationActa Haematologica, 1983
- Natural killer cell activity correlates with the amount of β2-microglobulin on human peripheral blood lymphocytesCellular Immunology, 1982
- Transferrin binding to K562 cell line *1Effect of heme and sodium butyrate inductionExperimental Cell Research, 1982